Stay updated on Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2 and removed the Back to Top element; no substantive changes to core content, pricing, or scheduling.
    Difference
    0.2%
    Check dated 2025-09-14T00:15:22.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content.
    Difference
    0.2%
    Check dated 2025-09-06T21:17:25.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The web page has been updated to include new facility and publication information related to Hodgkin lymphoma treatments, while several outdated terms and classifications have been removed.
    Difference
    10%
    Check dated 2025-08-30T15:42:52.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    33 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-08-16T12:40:36.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version (v2.16.11) and includes new dates for events or deadlines, specifically for August 2025 and December 2023. The previous version (v2.16.10) and several earlier dates have been removed.
    Difference
    1%
    Check dated 2025-08-09T08:08:48.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    The web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.
    Difference
    1%
    Check dated 2025-08-02T04:12:43.000Z thumbnail image

Stay in the know with updates to Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Doxorubicin-Pembrolizumab Combo in Hodgkin Lymphoma Clinical Trial page.